CareMax (CMAX) Competitors $2.06 -0.11 (-5.07%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CMAX vs. RNLX, PMD, MRAI, BRTX, OTRK, BGLC, KDLY, VSEE, NIVF, and OPGNShould you be buying CareMax stock or one of its competitors? The main competitors of CareMax include Renalytix (RNLX), Psychemedics (PMD), Marpai (MRAI), BioRestorative Therapies (BRTX), Ontrak (OTRK), BioNexus Gene Lab (BGLC), Kindly MD (KDLY), Vsee Health (VSEE), NewGenIvf Group (NIVF), and OpGen (OPGN). These companies are all part of the "healthcare" industry. CareMax vs. Renalytix Psychemedics Marpai BioRestorative Therapies Ontrak BioNexus Gene Lab Kindly MD Vsee Health NewGenIvf Group OpGen CareMax (NASDAQ:CMAX) and Renalytix (NASDAQ:RNLX) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment. Which has stronger valuation & earnings, CMAX or RNLX? Renalytix has lower revenue, but higher earnings than CareMax. Renalytix is trading at a lower price-to-earnings ratio than CareMax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareMax$751.10M0.01-$683.35M-$208.44-0.01Renalytix$2.29M7.50-$33.46M-$0.39-0.53 Do insiders & institutionals have more ownership in CMAX or RNLX? 65.9% of CareMax shares are held by institutional investors. Comparatively, 9.9% of Renalytix shares are held by institutional investors. 26.9% of CareMax shares are held by company insiders. Comparatively, 18.3% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is CMAX or RNLX more profitable? CareMax has a net margin of -99.78% compared to Renalytix's net margin of -1,461.60%. Renalytix's return on equity of 0.00% beat CareMax's return on equity.Company Net Margins Return on Equity Return on Assets CareMax-99.78% -175.40% -29.26% Renalytix -1,461.60%N/A -281.40% Do analysts rate CMAX or RNLX? CareMax currently has a consensus price target of $45.00, indicating a potential upside of 2,084.47%. Renalytix has a consensus price target of $3.00, indicating a potential upside of 1,348.58%. Given CareMax's higher probable upside, equities analysts plainly believe CareMax is more favorable than Renalytix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareMax 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Renalytix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in CMAX or RNLX? CareMax and Renalytix both received 9 outperform votes by MarketBeat users. However, 34.62% of users gave Renalytix an outperform vote while only 30.00% of users gave CareMax an outperform vote. CompanyUnderperformOutperformCareMaxOutperform Votes930.00% Underperform Votes2170.00% RenalytixOutperform Votes934.62% Underperform Votes1765.38% Which has more volatility and risk, CMAX or RNLX? CareMax has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.72, meaning that its share price is 172% more volatile than the S&P 500. Does the media prefer CMAX or RNLX? In the previous week, CareMax's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score. Company Overall Sentiment CareMax Neutral Renalytix Neutral SummaryRenalytix beats CareMax on 8 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get CareMax News Delivered to You Automatically Sign up to receive the latest news and ratings for CMAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMAX vs. The Competition Export to ExcelMetricCareMaxNursing & personal care facilities IndustryBusiness SectorNASDAQ ExchangeMarket Cap$7.87M$523.58M$6.52B$8.53BDividend YieldN/AN/A2.63%4.14%P/E Ratio-0.0116.1639.3915.14Price / Sales0.010.24215.8993.55Price / Cash0.024.8824.8234.04Price / Book0.131.574.565.02Net Income-$683.35M-$225.94M$114.67M$225.46M7 Day Performance27.16%6.62%-0.74%0.37%1 Month Performance25.61%4.78%-0.14%3.57%1 Year Performance-96.40%-14.38%23.61%29.42% CareMax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMAXCareMax3.4828 of 5 stars$2.06-5.1%$45.00+2,084.5%-96.2%$7.87M$751.10M-0.011,450News CoverageGap UpHigh Trading VolumeRNLXRenalytix1.2377 of 5 stars$0.21+5.7%$3.00+1,348.6%-79.7%$17.18M$2.29M-0.53100Gap UpPMDPsychemedicsN/A$2.32flatN/A-6.5%$13.47M$20.79M-2.97140Positive NewsMRAIMarpaiN/A$0.81flat$6.00+640.7%+76.9%$11.13M$37.15M-0.24150Gap DownBRTXBioRestorative Therapies4.0457 of 5 stars$1.53-3.2%$18.00+1,076.5%-12.2%$10.59M$174,100.00-0.757Short Interest ↓Positive NewsOTRKOntrak1.9959 of 5 stars$1.84+1.1%$45.00+2,345.7%-88.7%$7.76M$12.39M-0.05250Gap UpBGLCBioNexus Gene Lab0.9921 of 5 stars$0.38+2.7%N/A+3.9%$6.82M$9.18M0.0030Positive NewsKDLYKindly MDN/A$1.00+12.4%N/AN/A$5.94M$3.10M0.00N/ANews CoverageHigh Trading VolumeVSEEVsee HealthN/A$1.64-3.0%N/AN/A$5.91M$6.38M0.00N/AGap DownNIVFNewGenIvf Group0.7485 of 5 stars$0.80-4.7%N/AN/A$3.00M$5.14M0.00N/ANews CoverageOPGNOpGenN/A$1.78+11.3%N/A-72.0%$2.40M$2.67M0.00100Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies RNLX Alternatives PMD Alternatives MRAI Alternatives BRTX Alternatives OTRK Alternatives BGLC Alternatives KDLY Alternatives VSEE Alternatives NIVF Alternatives OPGN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CMAX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareMax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CareMax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMAX Stock Alerts